SCHEMBL3660246

SCHEMBL3660246

CCOC(=O)CN(Cc1ccc(OC)cc1OC)Cc1c(-c2cccs2)noc1C(=O)OCC.CCOC(=O)c1ncc2c(-c3cccs3)noc2c1O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 5/20 0.35
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
PTPN1 P18031 2/20 0.32
KCNK3 O14649 1/20 0.32
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2776688 0.91 MEN1 (0.42) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL3663330 0.88 PTPN1 (0.38) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL3660421 0.88 MAPT (0.36) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL3657976 0.87 POLB (0.39) MEN1KMT2AMAPTTSHRPOLB
SCHEMBL3660444 0.85 TP53 (0.35) MEN1KMT2AMAPTTP53POLB
SCHEMBL2777556 0.79 PTPN1 (0.43) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL2779106 0.79 POLB (0.41) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL2777919 0.78 MAPT (0.45) KMT2AMAPTTSHRLMNATP53
SCHEMBL2776138 0.78 POLB (0.47) MEN1KMT2AMAPTTSHRLMNA
SCHEMBL3663664 0.76 PTPN1 (0.41) MEN1KMT2AMAPTTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227475-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS Fibrogen, Inc. (US) 2010-09-15 EP disclosed
WO-2009073669-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS FIBROGEN, INC. (US) 2009-06-11 WO disclosed